Sangamo Therapeutics Inc Cash Flow Quality Index

Latest as of September 2024: 1.10x

Sangamo Therapeutics Inc cash flow quality index. Sangamo Therapeutics Inc (SGMO) has a Cash Flow Quality Index of 1.10x as of September 2024. Operating cash flow of $11.76 Million exceeds net income of $10.67 Million, indicating high earnings quality where cash backs reported profits. See Sangamo Therapeutics Inc (SGMO) flexibility index to measure the company's free cash flow as a share of total liabilities.

Cash Flow Quality Index

1.10x

Operating CF / Net Income

Operating Cash Flow

$11.76 Million

USD

Net Income

$10.67 Million

USD

Data as of

Sep 2024

Most recent filing

Sangamo Therapeutics Inc Cash Flow Quality Index by Year (None–None)

Sangamo Therapeutics Inc cash flow quality index by year from None to None. Year-by-year earnings quality comparison for Sangamo Therapeutics Inc. For the full cash flow conversion analysis, see SGMO cash flow conversion.

Year	Quality Index	Operating CF (USD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.